OXBDF - Oxford Biomedica Plc's (OXBDF) CEO John Dawson On Q2 2021 Results - Earnings Call Transcript

Oxford Biomedica plc (OXBDF) Q2 2021 Earnings Conference Call September 22, 2021 8:00 A.M. ET Company Participants Sophia Bolhassan - Director of Investor Relations John Dawson - Chief Executive Officer Kyri Mitrophanous - Chief Scientific Officer Stuart Paynter - Chief Financial Officer Conference Call Participants Amy Walker - Peel Hunt Alistair Campbell - Liberum Joe Pantginis - H.C. Wainwright Charles Weston - RBC Philippa Gardner - Jefferies Max Herrmann - Stifel Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide. Presentation Sophia Bolhassan 00:02 Good afternoon ladies and gentlemen, Welcome to Oxford Biomedica’s Half-Year Results Analyst Meeting and Conference Call for the six months ending thirty of June twenty twenty one.

For further details see:

Oxford Biomedica Plc's (OXBDF) CEO John Dawson On Q2 2021 Results - Earnings Call Transcript